Rachel Stolzenberg-Solomon, PhD, MPH

Public Health Interests

Biomarkers; Cancer; Cancer Epidemiology; Nutrition

Research Organizations

School of Public Health: Chronic Disease Epidemiology

Research Summary

Dietary, lifestyle, genetic and other risk factors for pancreatic cancer

Nutritional, molecular, and other biomarkers (i.e. metabolomics) and cancer

Selected Publications

  • The Healthy Eating Index-2005 and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study. Arem H, Reedy J, Sampson J, Jiao L, Hollenbeck AR, Risch H, Mayne ST, Stolzenberg-Solomon RZ. The Healthy Eating Index-2005 and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study. J Natl Cancer Inst 2013;105:1298-305. PubMed Central PMCID: PMC3760780.
  • Lifetime Adiposity and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Cohort. Stolzenberg-Solomon RZ, Schairer C, Moore S, Hollenbeck A, Silverman DT, Lifetime Adiposity and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Cohort. 2013;98:1057-65. PubMed Central PMCID: PMC3778860.
  • Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ. Vitamin D-binding protein and pancreatic cancer: a nested case-control study. Am J Clin Nutr Am J Clin Nutr. 2015;101:1206-15. PubMed Central PMCID: PMC4441803.
  • Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes. Loftfield E, Freedman ND, Lai GY, Weinstein SJ, McGlynn KA, Taylor PR, Mannisto S, Albanes D, Stolzenberg-Solomon RZ. Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes. Cancer Prev Res. 2016;9:866-874. PubMed Central PMCID: PMC5093066.
  • Identifying biomarkers of dietary patterns using metabolomics. Playdon MC, Moore SC, Derkach A, Reedy J, Subar AF, Sampson JN, Albanes D, Gu F Jukka Kontto, Lassale C, Liao L, Männistö S, Mondul AM, Weinstein SJ, Irwin ML, Mayne ST, Stolzenberg-Solomon R. Identifying biomarkers of dietary patterns using metabolomics. Am J Clin Nutr. 2017;105:450-465. PubMed Central PMCID: PMC5267308.
  • Childhood body mass index is associated with the risk of adult pancreatic cancer. Nogueira LM, *, Stolzenberg-Solomon RZ*, Gamborg M, Sørensen TIA, Baker J. Childhood body mass index is associated with the risk of adult pancreatic cancer. Curr Dev Nutr 2017; 1e001362.
  • Pancreatic cancer incidence trends and recent patterns by sex and racial/ethnic group: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Gordon-Dseagu, V.L., Devesa, S. S., Goggins, M., Stolzenberg-Solomon, R. Pancreatic cancer incidence trends and recent patterns by sex and racial/ethnic group: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol. 2017; PubMed PMID: 29149259.
  • Effects on metabolites of dietary sodium: The Dietary Approaches to Stop Hypertension-Sodium (DASH) feeding study. Derkach A, Sampson J, Joseph J, Playdon MC, Stolzenberg-Solomon RZ. Effects on metabolites of dietary sodium: The Dietary Approaches to Stop Hypertension-Sodium (DASH) feeding study. Am J Clin Nutr. 2017;106:1131-1141. PubMed Central PMCID: PMC5611778.
  • Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Klein A*, Wolpin BM*, Risch HA*, Stolzenberg-Solomon RZ*, Mocci E, Zhang M, Obazee O, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung C, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, Gaziano JMM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw K-T, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee I-M, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu X-O, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Canzian F, Petersen GM, Amundadottir LT. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Comm. 2017.

Edit this profile

Contact Info

Rachel Stolzenberg-Solomon, PhD, MPH